Minimalist IAS
Prelims 2025 paper

UPSC CSE Prelims 2025 · Question 48 · Biotechnology & genetics

With reference to monoclonal antibodies, often mentioned in news, consider the following statements:

Prelims 2025 · Q48

Biotechnology & genetics Easy

With reference to monoclonal antibodies, often mentioned in news, consider the following statements:

  1. I.They are man-made proteins.
  2. II.They stimulate immunological function due to their ability to bind to specific antigens.
  3. III.They are used in treating viral infections like that of Nipah virus.

Which of the statements given above are correct?

Answer & explanation

Answer: (d) I, II and III

All three statements are correct. Monoclonal antibodies are identical antibody proteins made in a laboratory, each locking on to one specific antigen, and one of them (m102.4) was kept ready in India to treat Nipah virus patients.

  • ✓ I They are antibodies, which are proteins, produced in the laboratory (for example from hybridoma cells), not by the patient's own body.
  • ✓ II Each one is designed to bind a single antigen with high precision, and that binding helps the immune system attack the target.
  • ✓ III The monoclonal antibody m102.4 was procured by ICMR for Nipah cases, and a facility to administer it was set up in Kerala during the 2019 outbreak.
  • • Since then WHO's fact sheet says there is no licensed specific treatment or vaccine for Nipah yet, so such antibodies are used on an emergency or experimental basis.

Remember · Monoclonal antibodies are lab-made, single-target antibody proteins; m102.4 is the one kept ready by ICMR against Nipah virus.

Sources

Question and answer: UPSC's official GS Paper I (2025, Series A) — paper ↗ · answer key ↗. Explanation: Minimalist IAS, checked 30 Sept 2026 (how we verify). ·

More on Biotechnology & genetics

All Biotechnology & genetics questions →

Same topic in the Mains syllabus